.png)
Objective: Gold standard therapy for obstructive sleep apnea syndrome (OSAS) is a positive airway pressure (PAP) treatment. Patient adherence is very important in PAP treatment. We aimed to investigate the parameters which could affect PAP treatment adherence, especially anxiety and depression levels.
Methodology: This study includes participants who had undergone a polysomnography test and who had been treated with PAP between December 2014 and December 2015. Sex, age, height, and weight data were collected. Patients treated with PAP were asked to answer questions from the Beck anxiety and depression inventories at their six-month control, Peak nasal inspiratory flow (PNIF) scores and were evaluated on adherence to PAP treatment. In this study, cases were grouped as compliant patients and noncompliant patients with regards to their PAP treatment.
Results: Nineteen of 72 patients included in the study were female, 53 were male, and their ages were between 25 and 69 (mean 46.76±11.19). Sixty of 72 patient treated with CPAP had severe OSAS, and 12 patients had medium OSAS. Mean Apnea-Hypopnea Index (AHI) score was 52.10±15.49 (26 .0-80.2). We observed that patients with Beck anxiety scores of 14 and higher were noncompatible with PAP treatment. Similarly, patients who scored lower than 95 L/min on PNIF score were considered to be noncompliant with treatment. When assessing patient adherence to PAP treatment, psychological parameters must be taken into consideration.
Conclusions: In our study, we observed that anxiety was high and PNIF score was low in patients who were noncompliant with PAP treatment.